共 50 条
- [21] ALTERNATING USE OF DIFFERENT JAK1/JAK2 INHIBITORS, A POSSIBLE THERAPEUTIC STRATEGY USEFUL IN PRIMARY MYELOFIBROSIS: A CASE REPORTHAEMATOLOGICA, 2020, 105 : 395 - 395Gutierrez, Lopez de Ocariz X.Vera, Guerrero E.Carreno, Gomez-Tarragona G.Buendia, Urena B.De Nicolas, Sol R.Hidalgo, Soto M.Lopez, Munoz N.Zamanillo, Herreros, IIniguez, Garcia R.Poza, Santaella M.Ayala, Diaz R.Martinez, Lopez J.
- [22] Discovery of triazolo [1,5-a ] pyridine derivatives as novel JAK1/2 inhibitorsBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (14)Lu, KuanWu, WeibinZhang, CunlongLiu, ZijianXiao, BorenYuan, ZigaoLi, AnqiChen, DaweiZhai, XinJiang, Yuyang
- [23] Allogeneic Stem Cell Transplantation in Patients with BCR-ABL-Negative Myeloproliferative Neoplasms Pretreated with JAK1/JAK2 InhibitorsBONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 402 - 403Barabanshikova, MariaMorozova, ElenaMoiseev, IvanVlasova, JuliaBaykov, VadimUshal, InnaRodionov, GennadijMoiseev, SergeyBarkhatov, IldarAfanasyeva, KsenijaBondarenko, SergeyAfanasyev, Boris
- [24] The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: Hit to leadBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7421 - 7425Siu, TonyKozina, Ekaterina S.Jung, JoonRosenstein, CraigMathur, AnjiliAltman, Michael D.Chan, GraceXu, LinBachman, EricMo, Jan-RungBouthillette, MelaneyRush, ThomasDinsmore, Christopher J.Marshall, C. GaryYoung, Jonathan R.
- [25] Discovery of 1-Methyl-1H-imidazole Derivatives as Potent Jak2 InhibitorsJOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (01) : 144 - 158Su, QibinIoannidis, StephanosChuaqui, ClaudioAlmeida, LynsieAlimzhanov, MaratBebernitz, GeraldineBell, KirstenBlock, MichaelHoward, TinaHuang, ShanHuszar, DennisRead, Jon A.Costa, Caroline RivardShi, JieSu, MeiYe, MinweiZinda, Michael
- [26] Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screeningBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) : 3598 - 3601Robert KissTimea PolgarKirabo, AnnetSayyah, JacquelineFigueroa, Nicholas C.List, Alan F.Sokol, LubomirZuckerman, Kenneth S.Gali, MeghanathBisht, Kirpal S.Sayeski, Peter P.Keseru, Gyorgy M.
- [27] Identifying novel JAK1 inhibitors by structure-based virtual screening: A case study of using drug discovery tools at mcule.comABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244Kiss, RobertSzalai, FerencSayeski, Peter P.Keseru, Gyoergy M.
- [28] The Small Molecule JAK1/JAK2 Inhibitor INCB16562 Shows Single Agent Activity and Strongly Synergizes with Bcl-2 Inhibitors in LymphomaBLOOD, 2011, 118 (21) : 1175 - 1175Derenzini, EnricoLemoine, ManuelaBrighenti, ElisaDavis, Richard EricZinzani, Pier LuigiYounes, Anas
- [29] Discovery and evaluation of Atopaxar hydrobromide, a novel JAK1 and JAK2 inhibitor, selectively induces apoptosis of cancer cells with constitutively activated STAT3Investigational New Drugs, 2020, 38 : 1003 - 1011Jingjie SunYuping DuXinxin ZhangZhuoya WangYuxi LinQiaoling SongXiao WangJihui GuoShanshan LiJing NanJinbo Yang
- [30] Discovery and evaluation of Atopaxar hydrobromide, a novel JAK1 and JAK2 inhibitor, selectively induces apoptosis of cancer cells with constitutively activated STAT3INVESTIGATIONAL NEW DRUGS, 2020, 38 (04) : 1003 - 1011Sun, JingjieDu, YupingZhang, XinxinWan, ZhuoyaLin, YuxiSong, QiaolingWang, XiaoGuo, JihuiLi, ShanshanNan, JingYang, Jinbo